巴勒斯坦9人死于甲型H1N1流感

2013-01-04 陈序 吕迎旭 新华社

  巴勒斯坦医疗部门官员12月29日说,自12月初以来共有189名生活在约旦河西岸的巴勒斯坦人被确诊感染甲型H1N1流感,其中9人死亡。   巴勒斯坦卫生部官员阿萨德当天接受新华社记者采访时说,大多数被确诊感染甲型H1N1流感的患者生活在约旦河西岸北部地区,但疫情正逐步向中部及南部扩散。   阿萨德说,巴勒斯坦卫生部已做好应对疫情扩散的准备,世界卫生组织已同意向巴方提供足够数量的甲

  巴勒斯坦医疗部门官员12月29日说,自12月初以来共有189名生活在约旦河西岸的巴勒斯坦人被确诊感染甲型H1N1流感,其中9人死亡。

  巴勒斯坦卫生部官员阿萨德当天接受新华社记者采访时说,大多数被确诊感染甲型H1N1流感的患者生活在约旦河西岸北部地区,但疫情正逐步向中部及南部扩散。

  阿萨德说,巴勒斯坦卫生部已做好应对疫情扩散的准备,世界卫生组织已同意向巴方提供足够数量的甲型H1N1流感疫苗。根据巴勒斯坦卫生部的统计,2011年共有12名巴勒斯坦人因患甲型H1N1流感而死亡。



    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1764366, encodeId=a3171e6436648, content=<a href='/topic/show?id=e7b069e6635' target=_blank style='color:#2F92EE;'>#甲型H1N1流感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69766, encryptionId=e7b069e6635, topicName=甲型H1N1流感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514c37720126, createdName=passed water, createdTime=Fri Oct 04 08:00:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469511, encodeId=34e314695114b, content=<a href='/topic/show?id=d46a83e3d8' target=_blank style='color:#2F92EE;'>#H1N1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8373, encryptionId=d46a83e3d8, topicName=H1N1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee77038498, createdName=TZF0806, createdTime=Sun Jan 06 03:00:00 CST 2013, time=2013-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631360, encodeId=1b29163136074, content=<a href='/topic/show?id=fda383e43b' target=_blank style='color:#2F92EE;'>#H1N1流感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8374, encryptionId=fda383e43b, topicName=H1N1流感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eee21750483, createdName=apoenzyme, createdTime=Sun Jan 06 03:00:00 CST 2013, time=2013-01-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1764366, encodeId=a3171e6436648, content=<a href='/topic/show?id=e7b069e6635' target=_blank style='color:#2F92EE;'>#甲型H1N1流感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69766, encryptionId=e7b069e6635, topicName=甲型H1N1流感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514c37720126, createdName=passed water, createdTime=Fri Oct 04 08:00:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469511, encodeId=34e314695114b, content=<a href='/topic/show?id=d46a83e3d8' target=_blank style='color:#2F92EE;'>#H1N1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8373, encryptionId=d46a83e3d8, topicName=H1N1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee77038498, createdName=TZF0806, createdTime=Sun Jan 06 03:00:00 CST 2013, time=2013-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631360, encodeId=1b29163136074, content=<a href='/topic/show?id=fda383e43b' target=_blank style='color:#2F92EE;'>#H1N1流感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8374, encryptionId=fda383e43b, topicName=H1N1流感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eee21750483, createdName=apoenzyme, createdTime=Sun Jan 06 03:00:00 CST 2013, time=2013-01-06, status=1, ipAttribution=)]
    2013-01-06 TZF0806
  3. [GetPortalCommentsPageByObjectIdResponse(id=1764366, encodeId=a3171e6436648, content=<a href='/topic/show?id=e7b069e6635' target=_blank style='color:#2F92EE;'>#甲型H1N1流感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69766, encryptionId=e7b069e6635, topicName=甲型H1N1流感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514c37720126, createdName=passed water, createdTime=Fri Oct 04 08:00:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469511, encodeId=34e314695114b, content=<a href='/topic/show?id=d46a83e3d8' target=_blank style='color:#2F92EE;'>#H1N1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8373, encryptionId=d46a83e3d8, topicName=H1N1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee77038498, createdName=TZF0806, createdTime=Sun Jan 06 03:00:00 CST 2013, time=2013-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631360, encodeId=1b29163136074, content=<a href='/topic/show?id=fda383e43b' target=_blank style='color:#2F92EE;'>#H1N1流感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8374, encryptionId=fda383e43b, topicName=H1N1流感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eee21750483, createdName=apoenzyme, createdTime=Sun Jan 06 03:00:00 CST 2013, time=2013-01-06, status=1, ipAttribution=)]